Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
4/18/24 AbbVie (ABBV) Rinvoq for Giant Cell Arteritis Subscribers Only Subscribers Only Subscribers Only
4/17/24 Eli Lilly (LLY) Mounjaro for Sleep Apnea Subscribers Only Subscribers Only Subscribers Only
4/16/24 Intra-Cellular Therapies (ITCI) Caplyta for Major Depressive Disorder (MDD) Subscribers Only Subscribers Only Subscribers Only
4/15/24 Novartis (NVS) Fabhalta for Immunoglobulin A (IgA) Nephropathy (Berger's Disease) Subscribers Only Subscribers Only Subscribers Only
4/15/24 Roche (RHHBY) Columvi for Diffuse Large B-Cell Lymphoma (DLBCL) - NHL Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
12/18/23 Subscribers Only Subscribers Only Progress Update - Product Launch (China)
03/01/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
03/19/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/09/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/15/24 Subscribers Only Subscribers Only Partnership - Acquisition Completion